日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

IRF4 Enhances Radiosensitivity of Cervical Cancer by Inhibiting the PI3K/Akt/mTOR Pathway to Regulate Autophagy.

IRF4 通过抑制 PI3K/Akt/mTOR 通路调节自噬来增强宫颈癌的放射敏感性。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70305
Gao Meihui, Cui Zhaolei, Song Huachun, Li Yanhong, Li Anyang, Zheng Jianfeng, Liu Linying, Lin Xuefen, Fu Wankai, Sun Yang
肿瘤
mTOR
肿瘤免疫
信号转导
PI3K/Akt
宫颈癌
Autophagy
自噬
发表日期：2026
文献求助 收藏

The PLANES model for unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus lenvatinib and PD-1 inhibitors: a multicenter, retrospective study

PLANES模型用于评估经导管动脉化疗栓塞联合乐伐替尼和PD-1抑制剂治疗不可切除肝细胞癌的效果：一项多中心回顾性研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1680956
Ya, Houxiang; Wang, Kai; Wu, Jiayi; Wu, Junyi; Zeng, Zhenxin; Li, Yinan; Ou, Xiangye; Song, Huachun; Yan, Maolin; Li, Shuqun
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway.

RBP7 敲低抑制人类肝细胞癌的增殖并激活 p38 MAPK 通路

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1592616
Li Jinhai, Zhai Huawei, Cai Fujing, Zhang Xian, Zhou Yu, Li Shuqun, Song Huachun, Zhang Haifeng, Sun Guangzheng, Zhu Minghui, Yuan Jing, Zhang Ningxin, Yan Maolin
细胞生物学
p38 MAPK
Human
发表日期：2025
文献求助 收藏

Combination Therapy of Transarterial Chemoembolization, Lenvatinib, and PD-1 Inhibitors Achieves Significant Tumor Response in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Report

经动脉化疗栓塞术、乐伐替尼和PD-1抑制剂联合治疗胆管癌栓患者可显著缓解肿瘤：病例报告

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S511319
Fu, Yangkai; Wu, Junyi; Wu, Jiayi; Li, Yinan; Zeng, Zhenxin; Liu, Deyi; Li, Han; Ou, Xiangye; Lin, Zhongtai; Wei, Shaoming; Song, Huachun; Yan, Maolin
肿瘤
胆管癌
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏